Not exact matches
Bank on it Sonders sees
financial stocks as cheap relative to their
potential for growth, with bank
earnings likely to get a boost from both rising interest rates and deregulation.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's
earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and
potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's
earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax
earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The bottom line with any investment is the quality of the firm's
financial position, prospects for
earnings growth over the next several years, dividend - growth
potential, and the strength and defensibility of its industry position.
While we currently favour global exposure to the technology sector and selected opportunities within healthcare, we're also positive on
financials — another giant within the Canadian market cap that we believe registers as fairly valued with the
potential for decent
earnings growth amid a synchronized and sustained global economic expansion.
High Risk — Income (H / INC) Medium to higher risk equities of companies that are structured with a focus on providing a meaningful dividend but may face less predictable
earnings (or losses), more leveraged balance sheets, rapidly changing market dynamics,
financial and competitive issues, higher price volatility (beta), and
potential risk of principal.
Medium Risk — Growth (M / GRW) Lower to average risk equities of companies with sound
financials, consistent
earnings growth, the
potential for long - term price appreciation, a
potential dividend yield, and / or share repurchase program.
The free online tool provided by Iowa Student Loan uses information from students» freshman year
financial aid award packets, as well as outside scholarships and grants and family savings and
earnings, to project estimated costs, funding gaps and
potential student loan debt over four years.
However, what most borrowers don't realize, is the interest rate and expected monthly payments are determined by several factors, including the borrower's past credit history, current
financial situation and future
earnings potential, the lender's costs and desired profit margin, and the loan repayment options the borrower selects.
They're looking for
financial sound firms whose
earnings have been growing lately and whose «reasonable company valuation indicat [es] a strong upside
potential in the stock price over the next 9 to 12 months.»
While we currently favour global exposure to the technology sector and selected opportunities within healthcare, we're also positive on
financials — another giant within the Canadian market cap that we believe registers as fairly valued with the
potential for decent
earnings growth amid a synchronized and sustained global economic expansion.
Choose each equity investment based on its discount from our appraisal of corporate intrinsic value, its
financial strength, its management, its competitive position, and our assessment of its future
earnings potential.
Missing out on
potential investment returns for that portion of their
financial portfolio could cost them extensively in foregone
earnings over the course of their lifetimes.
But actual
financial results of a company or a stock market over the past 12 months may not necessarily be a predictor of
potential earnings for the coming year.
Regardless of the metrics, I consider valuation a purely quantitative exercise, based almost entirely on past / present
financials — whereas a company's prospects &
potential earnings belong to another entirely separate qualitative analysis.
Again from a
financial perspective, the chief failing of PEP (and quarterly
earnings) is that they are potent distractions — alike to clients,
potential recruits, and the firm itself — from the ingredients that lead to long - term healthy growth.
If you have been injured on the job or while performing job - related duties, you're probably stressed about lost
earnings, lost earning
potential, and your current and future
financial situation.
In fact, protecting your
potential earnings is one of the cornerstones of
financial planning and is in fact foundational in effective risk management.
Note that your life insurance safety net may not need to replace your entire paycheck, depending on your
financial position and your spouse's current income or
earnings potential.
Clearly, bitcoin and, cryptocurrencies in general, offer a much high
earnings potential than established
financial assets, which is why so many investors are now diversifying into this new digital asset class.
A Finance Controller, or Business Controller, is directly responsible for the
financial reporting provided by companies and organization via the analyzing of
potential earnings and expenses and summarizing the company's
financial standing in accordance with regulatory guidelines.
Vice President of Finance, Director of Finance, Chief
Financial Officers (CFO), Controller, Tax Director, Compliance Director, Director of Risk Management, Accounting Director, Director of Pricing, Treasury Director; unlock your full career and
earnings potential by leveraging Canada's top ranked executive resume writers & career specialists.
Vice President of Finance, Director of Finance, Chief
Financial Officers (CFO), Controller, Tax Director, Compliance Director, Vice President of Retail Operations, Director of Risk Management, Accounting Director, Director of Pricing, Treasury Director; unlock your full career and
earnings potential by leveraging Canada's top ranked Executive Resume Writers & Career Specialists.
Eventually, I did hire a
financial advisor — «my guy» — but by then, I had lost years in
potential savings and
earnings because I didn't start out right out of college.
The problem is that these offshore transactions may turn out to be
financial transactions as opposed to property transactions, with the focus more on the initial increase in
earnings (due to favourable acquisition spreads and the assumed depreciation of the rand) as opposed to the longer - term impact on overall portfolio quality and growth
potential.
Although young associates seek the kind of unlimited
earnings potential real estate sales offers (78 percent say that's key), their most frequently cited reason for making a change in their affiliation is increased
financial security (51 percent) and not more money (32 percent).